title: Re: Cost-effectiveness of continuous subcutaneous apomorphine in the treatment of Parkinson's Disease in the UK and Germany.
authors.affiliation: a a Gillian Barnett and Associates Limited , Letterkenny , Ireland.
authors.forename: Gillian
authors.initials: G
authors.lastname: Barnett
authors.affiliation: b b University Hospitals Birmingham NHS Foundation Trust , Birmingham , UK.
authors.forename: Adrian C
authors.initials: AC
authors.lastname: Williams
mesh_terms: D000978:Antiparkinson Agents / Q000191:economics* / Q000627:therapeutic use*; D001058:Apomorphine / Q000191:economics* / Q000627:therapeutic use*; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy*
chemical_list: D000978:Antiparkinson Agents; D001058:Apomorphine